S
11.76
-0.13 (-1.05%)
| Penutupan Terdahulu | 11.89 |
| Buka | 11.72 |
| Jumlah Dagangan | 989,409 |
| Purata Dagangan (3B) | 1,071,193 |
| Modal Pasaran | 1,142,901,504 |
| Harga / Jualan (P/S) | 447.73 |
| Harga / Buku (P/B) | 5.75 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 Nov 2024 |
| Margin Operasi (TTM) | -1,051.64% |
| EPS Cair (TTM) | -0.500 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 4,900.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.05% |
| Nisbah Semasa (MRQ) | 12.56 |
| Aliran Tunai Operasi (OCF TTM) | -45.86 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -31.67 M |
| Pulangan Atas Aset (ROA TTM) | -16.22% |
| Pulangan Atas Ekuiti (ROE TTM) | -22.41% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | ARS Pharmaceuticals, Inc. | Menaik | Menaik |
AISkor Stockmoo
-0.4
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | -3.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.40 |
|
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 23.33% |
| % Dimiliki oleh Institusi | 68.33% |
| Julat 52 Minggu | ||
| Median | 30.00 (155.10%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Cantor Fitzgerald | 08 Oct 2024 | 30.00 (155.10%) | Beli | 13.88 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| CHAKMA JUSTIN | - | 12.50 | -194,605 | -2,455,126 |
| DORSEY BRIAN | - | 12.46 | -40,000 | -500,050 |
| LOWENTHAL RICHARD E | - | 12.95 | -100,000 | -1,295,000 |
| TANIMOTO SARINA | - | 12.95 | -100,000 | -1,295,000 |
| Jumlah Keseluruhan Kuantiti Bersih | -434,605 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -5,545,176 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 12.61 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| CHAKMA JUSTIN | Pegawai | 13 Dec 2024 | Jual (-) | 27,272 | 11.90 | 324,537 |
| CHAKMA JUSTIN | Pegawai | 13 Dec 2024 | Pelaksanaan pilihan | 27,272 | - | - |
| DORSEY BRIAN | Pegawai | 12 Dec 2024 | Jual (-) | 25,000 | 12.64 | 316,000 |
| DORSEY BRIAN | Pegawai | 12 Dec 2024 | Pelaksanaan pilihan | 25,000 | - | - |
| CHAKMA JUSTIN | Pegawai | 12 Dec 2024 | Jual (-) | 117,333 | 12.64 | 1,483,089 |
| CHAKMA JUSTIN | Pegawai | 12 Dec 2024 | Pelaksanaan pilihan | 117,333 | - | - |
| DORSEY BRIAN | Pegawai | 11 Dec 2024 | Jual automatik (-) | 15,000 | 12.27 | 184,050 |
| DORSEY BRIAN | Pegawai | 11 Dec 2024 | Pelaksanaan pilihan | 15,000 | - | - |
| LOWENTHAL RICHARD E | Pegawai | 10 Dec 2024 | Jual automatik (-) | 100,000 | 12.95 | 1,295,000 |
| TANIMOTO SARINA | Pegawai | 10 Dec 2024 | Jual automatik (-) | 100,000 | 12.95 | 1,295,000 |
| CHAKMA JUSTIN | Pegawai | 10 Dec 2024 | Jual (-) | 50,000 | 12.95 | 647,500 |
| CHAKMA JUSTIN | Pegawai | 10 Dec 2024 | Pelaksanaan pilihan | 50,000 | - | - |
| Papar semua | ||||||
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |